Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost–utility analysis alongside a randomized HYPO-RT-PC trial

BACKGROUND: Economic evidence for comparing low fraction with ultra-hypo fractionated (UHF) radiation therapy in the treatment of intermediate-to-high-risk prostate cancer (PC) is lacking, especially in Europe. This study presents an economic evaluation performed alongside an ongoing clinical trial....

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Sun, Jonsson, Håkan, Salén, Klas-Göran, Andén, Mats, Beckman, Lars, Fransson, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985558/
https://www.ncbi.nlm.nih.gov/pubmed/35587847
http://dx.doi.org/10.1007/s10198-022-01467-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985558/
https://www.ncbi.nlm.nih.gov/pubmed/35587847
http://dx.doi.org/10.1007/s10198-022-01467-5

Ejemplares similares